Clinical trial Recruiting at 1 site Observational

Prevalence and features of neuropathy in people with Waldenström's macroglobulinemia

Official title: Neuropathy in Waldenström's Macroglobulinemia: Pathophysiology, Prognosis and Treatment

Run by Copenhagen University Hospital, Rigshospitalet · NCT07160270 · Data updated 2026-11-12

This project will test whether questionnaires, clinical exams, nerve conduction tests, and blood/CSF markers can find and describe nerve damage in people with Waldenström's who have neuropathy.

More Peripheral Neuropathies trials

Quick facts

Study typeObservational
SexAll
Enrollment90 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations1 site (København Ø)
StatusRecruiting
StartedMay 14, 2025
Main results expectedDecember 30, 2025
Study endsDecember 30, 2025
Registry record updatedSeptember 8, 2025
Trial IDNCT07160270 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a confirmed diagnosis of Waldenström's macroglobulinemia who report symptoms consistent with peripheral neuropathy and are followed at Rigshospitalet.

Probably not a fit

Patients with WM who have no signs or symptoms of peripheral neuropathy are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cross-sectional observational project of a cohort of Waldenström's macroglobulinemia (WM) patients followed at Rigshospitalet. All identified WM patients were screened with a neuropathy questionnaire and those with probable symptoms will receive a neurological exam and nerve conduction study (ENG). Patients with WM-associated neuropathy will have blood tests including candidate biomarkers (for example neurofilament light chain) and lumbar puncture where indicated, with clinical classification of neuropathy subtypes. The cohort will be followed for three years to document clinical course and correlate paraclinical findings with outcomes.

Why it matters

Potential benefit: If successful, this could help clinicians diagnose WM-related neuropathy earlier and guide treatment decisions to reduce pain and disability.

How similar studies have gone: A few retrospective studies have reported heterogeneous clinical patterns and mechanisms, but prospective, systematic characterization like this is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of Waldenström's Macroglobulinemia with symptoms of peripheral neuropathy for further clinical investigation.

Exclusion Criteria:

* Investigated with no sign of peripheral neuropathy

Where it's running

  • Copenhagen Neuromuscular Center, Rigshospitalet Blegdamsvej.
    København Ø, Denmark
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.